CTLA4 and neoplasm: Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), one of the negative regulators of cytotoxic CD8+ T cells, has been targeted as a means to activate anti-tumor immune CTLs in mouse xenografts [11].